Skip to main content
Erschienen in: Cancer Causes & Control 5/2019

20.03.2019 | Original Paper

Global patterns and trends in the incidence of non-Hodgkin lymphoma

verfasst von: Adalberto Miranda-Filho, Marion Piñeros, Ariana Znaor, Rafael Marcos-Gragera, Eva Steliarova-Foucher, Freddie Bray

Erschienen in: Cancer Causes & Control | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Despite an increasing understanding of the pathology and genetics of non-Hodgkin lymphoma (NHL), global reports on variations in the incidence of NHL remain limited in their number and scope.

Methods

To provide a situation analysis, national incidence estimates for NHL in 185 countries for the year 2018 were obtained from the GLOBOCAN database. We also used recorded incidence data from Cancer Incidence in Five Continents (CI5) plus for years of diagnosis 1980–2012 to examine temporal trends.

Results

NHL ranked as the 5th to 9th most common cancer in most countries worldwide, with almost 510,000 new cases estimated in 2018. Observed incidence rates of NHL 2008–2012 varied markedly by world region: among males, rates were highest among Israel Jews [age-standardized (world) rate of 17.6 per 100,000), Australia (15.3), US whites (14.5), Canada (13.7), and Portugal (13.3)]. Where data were available, most populations exhibited stable or slightly increasing incidence rates; in North America, parts of Europe, and Oceania the rising incidence rates were generally observed until the 1990s, with a stabilization seen thereafter.

Conclusion

Marked variations in NHL incidence rates remain in populations in each world region. Special attention should be given to further etiological research on the role of endemic infections and environmental exposures, particularly in Africa, Asia, and Latin America. To permit internationally comparable statistics, an equal focus on addressing the quality of hematological information in population-based registries is also warranted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries: global cancer statistics 2018. CA Cancer J Clin. https://doi.org/10.3322/caac.21492 CrossRef Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries: global cancer statistics 2018. CA Cancer J Clin. https://​doi.​org/​10.​3322/​caac.​21492 CrossRef
2.
Zurück zum Zitat Weltgesundheitsorganisation (2017). WHO classification of tumours of haematopoietic and lymphoid tissues, Revised 4th edn. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) World Health Organization classification of tumours. International Agency for Research on Cancer, Lyon, p 585 Weltgesundheitsorganisation (2017). WHO classification of tumours of haematopoietic and lymphoid tissues, Revised 4th edn. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) World Health Organization classification of tumours. International Agency for Research on Cancer, Lyon, p 585
3.
Zurück zum Zitat Armitage JO, Gascoyne RD, Lunning MA, Cavalli F (2017) Non-Hodgkin lymphoma. Lancet 390(10091):298–310CrossRefPubMed Armitage JO, Gascoyne RD, Lunning MA, Cavalli F (2017) Non-Hodgkin lymphoma. Lancet 390(10091):298–310CrossRefPubMed
5.
Zurück zum Zitat Boffetta P (2011) I. Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol 22(Supplement 4):iv27–iv31CrossRef Boffetta P (2011) I. Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol 22(Supplement 4):iv27–iv31CrossRef
6.
Zurück zum Zitat Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 391(10125):1023–1075CrossRefPubMedPubMedCentral Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 391(10125):1023–1075CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF et al (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014(48):130–144CrossRefPubMedPubMedCentral Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF et al (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014(48):130–144CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S (2016) Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4(9):e609–e616CrossRefPubMed Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S (2016) Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4(9):e609–e616CrossRefPubMed
10.
Zurück zum Zitat Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA (2014) Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS 28(15):2313–2318CrossRefPubMedPubMedCentral Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA (2014) Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS 28(15):2313–2318CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed
14.
Zurück zum Zitat Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (eds) (2017) Cancer incidence in five continents, Vol. XI (electronic version). International Agency for Research on Cancer, Lyon. Available from: http://ci5.iarc.fr. Accessed 20 Aug 2018 Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (eds) (2017) Cancer incidence in five continents, Vol. XI (electronic version). International Agency for Research on Cancer, Lyon. Available from: http://​ci5.​iarc.​fr. Accessed 20 Aug 2018
15.
Zurück zum Zitat Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (eds) (2017) Cancer incidence in five continents plus, (time trends) (electronic version). International Agency for Research on Cancer, Lyon. http://ci5.iarc.fr/CI5plus/Default.aspx. Accessed 22 Sep 2018 Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (eds) (2017) Cancer incidence in five continents plus, (time trends) (electronic version). International Agency for Research on Cancer, Lyon. http://​ci5.​iarc.​fr/​CI5plus/​Default.​aspx. Accessed 22 Sep 2018
17.
Zurück zum Zitat Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–1957). Tohoku University School of Medicine, Sendai Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–1957). Tohoku University School of Medicine, Sendai
18.
Zurück zum Zitat Jensen OM, International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries (eds) (1991) Cancer registration: principles and methods, IARC scientific publications. International Agency for Research on Cancer, Lyon, p 288 Jensen OM, International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries (eds) (1991) Cancer registration: principles and methods, IARC scientific publications. International Agency for Research on Cancer, Lyon, p 288
19.
Zurück zum Zitat R Development Core Team. R Development Core Team (2014) R: a language and environment for statistical computing (computer programme). R Foundation for Statistical Computing, Vienna R Development Core Team. R Development Core Team (2014) R: a language and environment for statistical computing (computer programme). R Foundation for Statistical Computing, Vienna
20.
Zurück zum Zitat Østgård LSG, Nørgaard M, Nørgaard JM, Severinsen MT, Sengeløv H, Friis LS et al (2013) Data quality in the Danish national acute leukemia registry: a hematological data resource. Clin Epidemiol 5:335CrossRefPubMedPubMedCentral Østgård LSG, Nørgaard M, Nørgaard JM, Severinsen MT, Sengeløv H, Friis LS et al (2013) Data quality in the Danish national acute leukemia registry: a hematological data resource. Clin Epidemiol 5:335CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat McKay P, Fielding P, Gallop-Evans E, Hall GW, Lambert J, Leach M et al (2016) Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma. Br J Haematol 172(1):32–43CrossRefPubMed McKay P, Fielding P, Gallop-Evans E, Hall GW, Lambert J, Leach M et al (2016) Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma. Br J Haematol 172(1):32–43CrossRefPubMed
22.
Zurück zum Zitat Eichenauer DA, Thielen I, Haverkamp H, Franklin J, Behringer K, Halbsguth T et al (2014) Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin study group. Blood 123(11):1658–1664CrossRefPubMed Eichenauer DA, Thielen I, Haverkamp H, Franklin J, Behringer K, Halbsguth T et al (2014) Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin study group. Blood 123(11):1658–1664CrossRefPubMed
24.
Zurück zum Zitat Weltgesundheitsorganisation, Swerdlow SH, International Agency for Research on Cancer (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues: [… reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25–27, 2007, World Health Organization classification of tumours, 4 edn. International Agency for Research on Cancer, Lyon. p 439 Weltgesundheitsorganisation, Swerdlow SH, International Agency for Research on Cancer (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues: [… reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25–27, 2007, World Health Organization classification of tumours, 4 edn. International Agency for Research on Cancer, Lyon. p 439
25.
Zurück zum Zitat Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM (2016) EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management: EBV+ DLBCL 2016 update. Am J Hematol 91(5):529–537CrossRefPubMed Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM (2016) EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management: EBV+ DLBCL 2016 update. Am J Hematol 91(5):529–537CrossRefPubMed
26.
Zurück zum Zitat Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390CrossRefPubMedPubMedCentral Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D’Souza G et al (2015) Cumulative incidence of cancer among persons with HIV in North America: a cohort study. Ann Intern Med 163(7):507–518CrossRefPubMedPubMedCentral Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D’Souza G et al (2015) Cumulative incidence of cancer among persons with HIV in North America: a cohort study. Ann Intern Med 163(7):507–518CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Chaabna K, Bray F, Wabinga HR, Chokunonga E, Borok M, Vanhems P et al (2013) Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?: trends of KS incidence in Zimbabwe and Uganda. Int J Cancer 133(5):1197–1203CrossRefPubMed Chaabna K, Bray F, Wabinga HR, Chokunonga E, Borok M, Vanhems P et al (2013) Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?: trends of KS incidence in Zimbabwe and Uganda. Int J Cancer 133(5):1197–1203CrossRefPubMed
29.
Zurück zum Zitat Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katangole-Mbidde E, Wabinga H et al (2000) Non-Hodgkin lymphoma in Uganda: a case–control study. AIDS 14(18):2929–2936(CrossRefPubMed Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katangole-Mbidde E, Wabinga H et al (2000) Non-Hodgkin lymphoma in Uganda: a case–control study. AIDS 14(18):2929–2936(CrossRefPubMed
30.
Zurück zum Zitat Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S et al (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164(4):536–545CrossRefPubMed Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S et al (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164(4):536–545CrossRefPubMed
31.
Zurück zum Zitat Engels EA, Cho ER, Jee SH (2010) Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 11(9):827–834CrossRefPubMedPubMedCentral Engels EA, Cho ER, Jee SH (2010) Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 11(9):827–834CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Kim H, Shin AR, Chung HH, Kim MK, Lee JS, Shim J-J et al (2013) Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med 28(4):413–419CrossRefPubMedPubMedCentral Kim H, Shin AR, Chung HH, Kim MK, Lee JS, Shim J-J et al (2013) Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med 28(4):413–419CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Arisawa K, Soda M, Endo S, Kurokawa K, Katamine S, Shimokawa I et al (2000) Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 85(3):319–324CrossRefPubMed Arisawa K, Soda M, Endo S, Kurokawa K, Katamine S, Shimokawa I et al (2000) Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 85(3):319–324CrossRefPubMed
34.
Zurück zum Zitat Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068CrossRefPubMed Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068CrossRefPubMed
35.
Zurück zum Zitat Perry AM, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M et al (2016) Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the international non-Hodgkin lymphoma classification project. Haematologica 101(10):1244–1250CrossRefPubMedPubMedCentral Perry AM, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M et al (2016) Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the international non-Hodgkin lymphoma classification project. Haematologica 101(10):1244–1250CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat van Leeuwen MT, Turner JJ, Joske DJ, Falster MO, Srasuebkul P, Meagher NS et al (2014) Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006: lymphoid neoplasms in Australia 1982–2006. Int J Cancer 135(9):2146–2156CrossRefPubMed van Leeuwen MT, Turner JJ, Joske DJ, Falster MO, Srasuebkul P, Meagher NS et al (2014) Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006: lymphoid neoplasms in Australia 1982–2006. Int J Cancer 135(9):2146–2156CrossRefPubMed
37.
Zurück zum Zitat Marcos-Gragera R, Pollán M, Chirlaque MD, Gumà J, Sanchez MJ, Garau I et al (2010) Attenuation of the epidemic increase in non-Hodgkin’s lymphomas in Spain. Ann Oncol 21(Suppl 3):iii90–iii96PubMed Marcos-Gragera R, Pollán M, Chirlaque MD, Gumà J, Sanchez MJ, Garau I et al (2010) Attenuation of the epidemic increase in non-Hodgkin’s lymphomas in Spain. Ann Oncol 21(Suppl 3):iii90–iii96PubMed
38.
Zurück zum Zitat Adamson P, Bray F, Costantini AS, Tao M-H, Weiderpass E, Roman E (2007) Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 43(2):391–401CrossRefPubMed Adamson P, Bray F, Costantini AS, Tao M-H, Weiderpass E, Roman E (2007) Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 43(2):391–401CrossRefPubMed
39.
Zurück zum Zitat Clarke CA, Glaser SL (2002) Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94(7):2015–2023CrossRefPubMed Clarke CA, Glaser SL (2002) Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94(7):2015–2023CrossRefPubMed
Metadaten
Titel
Global patterns and trends in the incidence of non-Hodgkin lymphoma
verfasst von
Adalberto Miranda-Filho
Marion Piñeros
Ariana Znaor
Rafael Marcos-Gragera
Eva Steliarova-Foucher
Freddie Bray
Publikationsdatum
20.03.2019
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 5/2019
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-019-01155-5

Weitere Artikel der Ausgabe 5/2019

Cancer Causes & Control 5/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.